Schedule 13G ownership disclosure

Nabriva Therapeutics AG

Security class unavailable · CUSIP: 62957M104

Event date: 2019-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.7400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-187447
Form type
SC 13G/A
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Jul 01, 2019
Reporting period
Jun 28, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub